RA Capital Management’s Apogee Therapeutics APGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-1,569,491
| Closed | -$58.6M | – | 66 |
|
|
2025
Q1 | $58.6M | Hold |
1,569,491
| – | – | 0.98% | 22 |
|
|
2024
Q4 | $71.1M | Sell |
1,569,491
-392,372
| -20% | -$17.8M | 0.95% | 25 |
|
|
2024
Q3 | $115M | Hold |
1,961,863
| – | – | 1.33% | 22 |
|
|
2024
Q2 | $77.2M | Sell |
1,961,863
-16,038
| -0.8% | -$631K | 1.02% | 27 |
|
|
2024
Q1 | $131M | Hold |
1,977,901
| – | – | 1.67% | 18 |
|
|
2023
Q4 | $55.3M | Hold |
1,977,901
| – | – | 0.86% | 29 |
|
|
2023
Q3 | $42.1M | Buy |
+1,977,901
| New | +$42.1M | 0.83% | 34 |
|